Pay Bill Online

Cross Linking

What is Corneal Cross-Linking?

Corneal cross-linking (CXL) is a treatment that strengthens the cornea — the clear, dome-shaped surface at the front of the eye. In conditions such as keratoconus, the cornea becomes thin and weak, causing it to bulge outward into a cone shape. This leads to blurred or distorted vision that glasses or contact lenses cannot fully correct.

Cross-linking uses a special combination of vitamin B (riboflavin) eye drops and ultraviolet (UV-A) light to make the cornea stronger and more stable, preventing it from getting thinner or changing shape further.

How the Procedure Works

1

Riboflavin (vitamin B) drops are applied to the surface of the cornea

2

The cornea is then exposed to gentle UV-A light for about 20–30 minutes

3

The light activates the riboflavin, creating new chemical bonds (cross-links) between the collagen fibers in the cornea.

These new bonds make the cornea stronger and more resistant to deformation.

Benefits for Patients

  • Stops or slows the progression of keratoconus and other corneal ectatic disorders.
  • May slightly improve vision and make contact lenses fit better.
  • Reduces or delays the need for a corneal transplant.
  • Provides long-term stability and preservation of vision.

What Patients Should Know

  • Some temporary discomfort, blurred vision, or light sensitivity is normal after the procedure.
  • Vision typically stabilizes or improves over the following weeks to months.
  • The procedure is considered safe and effective when performed by an experienced ophthalmologist.

Summary

Corneal cross-linking is a modern, minimally invasive treatment that helps preserve your vision by reinforcing the cornea’s natural structure. It offers lasting protection against further vision loss in patients with keratoconus and related conditions.